Patient Preference of Apalutamide Versus Enzalutamide for Recurrent or Metastatic Hormone-sensitive Prostate Cancer: An Open-label, Randomized, Crossover Trial
Titel:
Patient Preference of Apalutamide Versus Enzalutamide for Recurrent or Metastatic Hormone-sensitive Prostate Cancer: An Open-label, Randomized, Crossover Trial
Auteur:
Ng, Chi-Fai Yee, Chi-Hang Chiu, Peter Ka-Fung Wong, Kenneth Lam, Daisy Yuen, Violet Wai-Fan Lai, Pui-Tak Teoh, Jeremy Yuen-Chun